Gregersen Peter K, Lee Hye-Soon, Batliwalla Franak, Begovich Ann B
Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, North Shore LIJ Health System, 350 Community Drive, Manhasset, NY 11030, United States.
Semin Immunol. 2006 Aug;18(4):214-23. doi: 10.1016/j.smim.2006.03.009. Epub 2006 May 30.
The 620W allelic variant of the intracellular tyrosine phosphatase, PTPN22, is associated with a number of different autoimmune disorders, and this provides direct evidence for common mechanisms underlying many of these diseases. The associated allele appears to influence thresholds for T cell receptor signaling, and a variety of disease models involving both central and peripheral tolerance can be proposed. However, given the fact that PTPN22 is expressed in a variety of immunologically relevant cell types, the precise mechanisms for these associations remain unclear. In general, the PTPN22 620W allele appears to play a role in autoimmune disorders that have a prominent humoral component, suggesting that further investigation of PTPN22 activity in B cells will be useful. From a genetic perspective, the data highlights the genetic heterogeneity underlying autoimmunity in different ethnic groups.
细胞内酪氨酸磷酸酶PTPN22的620W等位基因变体与多种不同的自身免疫性疾病相关,这为许多此类疾病背后的共同机制提供了直接证据。相关等位基因似乎会影响T细胞受体信号传导的阈值,并且可以提出涉及中枢和外周耐受的多种疾病模型。然而,鉴于PTPN22在多种免疫相关细胞类型中表达,这些关联的确切机制仍不清楚。一般来说,PTPN22 620W等位基因似乎在具有显著体液成分的自身免疫性疾病中起作用,这表明进一步研究B细胞中PTPN22的活性将是有用的。从遗传学角度来看,这些数据突出了不同种族自身免疫性疾病背后的遗传异质性。